World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

WORD

HTML

1953

Figures (1-1)

368

Tables (1-4)

357

Sum=2786

Publishing Process of This Article

Item

Count

Browse

161

Download

510

Sum=671

Nov 27, 2023 (publication date) through Apr 18, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Ward JA, Yerke J, Lumpkin M, Kapoor A, Lindenmeyer CC, Bass S. Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy. World J Hepatol 2023; 15(11): 1226-1236 [PMID: 38075005 DOI: 10.4254/wjh.v15.i11.1226]
URL:	https://www.wjgnet.com/1948-5182/full/v15/i11/1226.htm

Number	Citing Articles
1	Lorenzo Ridola, Alessandro Mari. Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy. World Journal of Hepatology 2024; 16(11): 1356-1360 doi: 10.4254/wjh.v16.i11.1356 Abstract(206) \| Core Tip(212) \| Full Article(HTML)(711) \| Full Article with Cover (PDF)-2476K(38) \| Audio-16465K(2) \| Peer-Review Report-394K(24) \| Answering Reviewers-69K(36) \| Full Article (PDF)-369K(53) \| Full Article (XML)-59K(32) \| Times Cited (0) \| Total Visits (1808) \| Open
2	Chien-Hao Huang, Piero Amodio. Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment?. World Journal of Hepatology 2024; 16(2): 115-119 doi: 10.4254/wjh.v16.i2.115 Abstract(500) \| Core Tip(415) \| Full Article(HTML)(2011) \| Full Article with Cover (PDF)-875K(107) \| Full Article (Word)-129K(13) \| Audio-162K(14) \| Peer-Review Report-172K(50) \| Answering Reviewers-129K(53) \| Full Article (PDF)-363K(109) \| Full Article (XML)-64K(54) \| Times Cited (0) \| Total Visits (5321) \| Open
3	Zhaohui Bai, Congcong Li, Yongjie Lai, Xiaojuan Hu, Luwen Shi, Xiaodong Guan, Yang Xu. Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis. Antibiotics 2025; 14(3): 287 doi: 10.3390/antibiotics14030287